Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Keegan

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Seminars in Neurology|May 28, 2013
Therapeutic decision making in a new drug era in multiple sclerosisB Mark Keegan
Multiple Sclerosis and Related Disorders|March 7, 2025
Markedly elevated cerebrospinal fluid white blood cell count in multiple sclerosis: How high is too high?Samar Ikram, B Mark Keegan
Annual Review of Medicine|January 31, 2002
Multiple sclerosisB Mark Keegan, John H Noseworthy
Neurologic Clinics|November 29, 2012
Paraneoplastic myelopathyEoin P Flanagan, B Mark Keegan
The Journal of ECT|September 7, 2007
Electroconvulsive therapy in patients with multiple sclerosisKeith G Rasmussen, B Mark Keegan
Multiple Sclerosis and Related Disorders|May 1, 2018
Trident sign trumps Aquaporin-4-IgG ELISA in diagnostic value in a case of longitudinally extensive transverse myelitisEvan A Jolliffe, B Mark Keegan, Eoin P Flanagan
Archives of Neurology|September 16, 2009
Multiple sclerosis with predominant, severe cognitive impairmentNathan P Staff, Claudia F Lucchinetti, B Mark Keegan
Neurology|February 11, 2012
Solitary sclerosis: progressive myelopathy from solitary demyelinating lesionWilliam F Schmalstieg, B Mark Keegan, Brian G Weinshenker
Neurology. Clinical Practice|August 12, 2014
Dementia in MS complicated by coexistent Alzheimer disease: Diagnosis premortem and postmortemEoin P Flanagan, David S Knopman, B Mark Keegan
Annals of Neurology|February 29, 2008
Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin GB Mark Keegan, Sean J Pittock, Vanda A Lennon
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Seminars in Neurology|May 28, 2013
Therapeutic decision making in a new drug era in multiple sclerosisB Mark Keegan
Multiple Sclerosis and Related Disorders|March 7, 2025
Markedly elevated cerebrospinal fluid white blood cell count in multiple sclerosis: How high is too high?Samar Ikram, B Mark Keegan
Annual Review of Medicine|January 31, 2002
Multiple sclerosisB Mark Keegan, John H Noseworthy
Neurologic Clinics|November 29, 2012
Paraneoplastic myelopathyEoin P Flanagan, B Mark Keegan
The Journal of ECT|September 7, 2007
Electroconvulsive therapy in patients with multiple sclerosisKeith G Rasmussen, B Mark Keegan
Multiple Sclerosis and Related Disorders|May 1, 2018
Trident sign trumps Aquaporin-4-IgG ELISA in diagnostic value in a case of longitudinally extensive transverse myelitisEvan A Jolliffe, B Mark Keegan, Eoin P Flanagan
Archives of Neurology|September 16, 2009
Multiple sclerosis with predominant, severe cognitive impairmentNathan P Staff, Claudia F Lucchinetti, B Mark Keegan
Neurology|February 11, 2012
Solitary sclerosis: progressive myelopathy from solitary demyelinating lesionWilliam F Schmalstieg, B Mark Keegan, Brian G Weinshenker
Neurology. Clinical Practice|August 12, 2014
Dementia in MS complicated by coexistent Alzheimer disease: Diagnosis premortem and postmortemEoin P Flanagan, David S Knopman, B Mark Keegan
Annals of Neurology|February 29, 2008
Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin GB Mark Keegan, Sean J Pittock, Vanda A Lennon
Pageof 9